These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15627108)

  • 21. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream.
    Welsh O; Olazarán Z; Gómez M; Salas J; Berman B
    J Am Acad Dermatol; 2004 Oct; 51(4):639-42. PubMed ID: 15389206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive squamous cell carcinoma treated with imiquimod 5% cream.
    Flórez A; Feal C; de la Torre C; Cruces M
    Acta Derm Venereol; 2004; 84(3):227-8. PubMed ID: 15202841
    [No Abstract]   [Full Text] [Related]  

  • 23. Imiquimod in the treatment of extensive recurrent lentigo maligna.
    Kamin A; Eigentler TK; Radny P; Bauer J; Weide B; Garbe C
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):51-2. PubMed ID: 15692515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
    Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
    Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic efficacy of topical imiquimod cream on keratoacanthoma: A retrospective single-center study.
    Lee JW; Cho KH; Choi CW; Jo SJ
    J Am Acad Dermatol; 2022 Sep; 87(3):671-674. PubMed ID: 34474080
    [No Abstract]   [Full Text] [Related]  

  • 26. Imiquimod: a topically applied link between innate and acquired immunity.
    Hurwitz DJ; Pincus L; Kupper TS
    Arch Dermatol; 2003 Oct; 139(10):1347-50. PubMed ID: 14568839
    [No Abstract]   [Full Text] [Related]  

  • 27. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
    Neville JA; Williford PM; Jorizzo JL
    J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.
    Marks R; Owens M; Walters SA;
    Arch Dermatol; 2004 Oct; 140(10):1284-5. PubMed ID: 15492200
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara).
    Didona B; Benucci R; Amerio P; Canzona F; Rienzo O; Cavalieri R
    Br J Dermatol; 2004 Jun; 150(6):1198-201. PubMed ID: 15214911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solitary plaque mycosis fungoides on the penis responding to topical imiquimod therapy.
    Chiam LY; Chan YC
    Br J Dermatol; 2007 Mar; 156(3):560-2. PubMed ID: 17300249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical evidence and the role of imiquimod in the extramammary Paget disease.
    Iavazzo C; Ntziora F; Karachalios C; Evangelia Iavazzo P; Gkegkes ID
    Acta Dermatovenerol Croat; 2014; 22(2):103-9. PubMed ID: 25102795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of cutaneous locoregional recurrences of melanoma: a new therapeutic perspective with imiquimod.
    Vereecken P; Mathieu A; Laporte M; Petein M; Velu T; Awada A; Heenen M
    Dermatology; 2003; 206(3):279-80. PubMed ID: 12673091
    [No Abstract]   [Full Text] [Related]  

  • 33. Imiquimod and superficial skin cancers.
    Naylor M
    J Drugs Dermatol; 2005; 4(5):598-606. PubMed ID: 16167419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
    Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
    Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod.
    Michalopoulos P; Yawalkar N; Brönnimann M; Kappeler A; Braathen LR
    Br J Dermatol; 2004 Oct; 151(4):903-6. PubMed ID: 15491436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eradication of basal cell cancer in an HIV positive patient with topical imiquimod.
    Scott DR
    J Drugs Dermatol; 2004; 3(6):602. PubMed ID: 15624742
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream.
    Deeths MJ; Chapman JT; Dellavalle RP; Zeng C; Aeling JL
    J Am Acad Dermatol; 2005 Feb; 52(2):275-80. PubMed ID: 15692473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases.
    Senchak AJ; Dann M; Cable B; Bessinger G
    Ear Nose Throat J; 2010 Mar; 89(3):E21-5. PubMed ID: 20229466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
    van Meurs T; van Doorn R; Kirtschig G
    Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589
    [No Abstract]   [Full Text] [Related]  

  • 40. Unilesional mycosis fungoides successfully treated with imiquimod.
    Ardigò M; Cota C; Berardesca E
    Eur J Dermatol; 2006; 16(4):446. PubMed ID: 16935811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.